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Problem
The diagnosis of microbial invasion of the amniotic cavity (MIAC) has
been traditionally performed using traditional cultivation techniques,
which require growth of microorganisms in the laboratory. Shortcom-
ings of culture methods include the time required (days) for identifica-
tion of microorganisms, and that many microbes involved in the genesis
of human diseases are difficult to culture. A novel technique combines
broad-range real-time polymerase chain reaction with electrospray ioni-
zation time-of-flight mass spectrometry (PCR/ESI-MS) to identify and
quantify genomic material from bacteria and viruses.
Method of study
AF samples obtained by transabdominal amniocentesis from 142 women
with preterm labor and intact membranes (PTL) were analyzed using cul-
tivation techniques (aerobic, anaerobic, and genital mycoplasmas) as well
as PCR/ESI-MS. The prevalence and relative magnitude of intra-amniotic
inflammation [AF interleukin 6 (IL-6) concentration ≥ 2.6 ng/mL],
acute histologic chorioamnionitis, spontaneous preterm delivery, and
perinatal mortality were examined.
Results
(i) The prevalence of MIAC in patients with PTL was 7% using standard
cultivation techniques and 12% using PCR/ESI-MS; (ii) seven of ten
patients with positive AF culture also had positive PCR/ESI-MS [≥17
genome equivalents per PCR reaction well (GE/well)]; (iii) patients with
positive PCR/ESI-MS (≥17 GE/well) and negative AF cultures had signif-
icantly higher rates of intra-amniotic inflammation and acute histologic
chorioamnionitis, a shorter interval to delivery [median (interquartile
range-IQR)], and offspring at higher risk of perinatal mortality, than
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doi:10.1111/aji.12189 women with both tests negative [90% (9/10) versus 32% (39/122) OR:
5.6; 95% CI: 1.4–22; (P < 0.001); 70% (7/10) versus 35% (39/112);
(P = 0.04); 1 (IQR: <1–2) days versus 25 (IQR: 5–51) days; (P = 0.002),
respectively]; (iv) there were no significant differences in these out-
comes between patients with positive PCR/ESI-MS (≥17 GE/well) who
had negative AF cultures and those with positive AF cultures; and (v)
PCR/ESI-MS detected genomic material from viruses in two patients
(1.4%).
Conclusion
(i) Rapid diagnosis of intra-amniotic infection is possible using PCR/ESI-
MS; (ii) the combined use of biomarkers of inflammation and PCR/ESI-
MS allows for the identification of specific bacteria and viruses in
women with preterm labor and intra-amniotic infection; and (iii) this
approach may allow for administration of timely and specific interven-
tions to reduce morbidity attributed to infection-induced preterm birth.
Introduction
Preterm birth is the leading cause of perinatal mor-
bidity and mortality worldwide.1–6 Microbial inva-
sion of the amniotic cavity (MIAC), determined with
cultivation techniques, occurs in one of every four
women who deliver preterm;7–43 yet, this may be an
underestimation because the diagnosis of MIAC
represents a challenge.
At first, transcervical catheters were used to evalu-
ate the microbial state of the amniotic cavity;44–49
however, this approach was abandoned because of
the problem of contamination. Subsequently, amnio-
centeses for the retrieval of amniotic fluid (AF) for
culture became the ’gold standard’ for the diagnosis
of MIAC.10,11,15,16,19,24,42,50–66 A major challenge
using this approach is that culture results take sev-
eral days to become available. This delay has led to
the standard practice of initiating intravenous anti-
microbial agents for patients with a positive Gram
stain or indicators of inflammation prior to identify-
ing the microorganism responsible for a suspected
infection.67–75 The latter assumes that inflammation
is always due to infection, and this is not the
case.76–80
Rapid tests are needed to determine whether and
which antimicrobial agents should be administered.
Other decisions, such as the administration or dis-
continuation of tocolysis or timing of the delivery,
also depend on the availability of reliable informa-
tion about the presence of microorganisms in the
amniotic cavity. The use of polymerase chain reac-
tion (PCR)-based techniques for the diagnosis of
infectious diseases can provide results in time for
rapid decision-making.81–88 Moreover, these tech-
niques can improve the detection of microbes diffi-
cult to culture,34,39,42,65,89–102 as well as provide
information about antimicrobial resistance and vir-
ulence factors.85,103–105 It is unknown whether
these techniques can be used at the point of care
to inform treatment decisions in an obstetrical set-
ting.
In this study of patients with spontaneous preterm
labor and intact membranes (PTL), AF culture was
compared to a new technique which combines
broad-range real-time PCR with electrospray
ionization time-of-flight mass spectrometry (PCR/
ESI-MS).106–114 This technique is capable of identify-
ing the genus and species of microorganisms in AF
within 8 hours and, therefore, in time for clinical
decisions.106,107,109–114 PCR/ESI-MS has been vali-
dated 106,114–134 and has the potential to revolution-
ize the detection of infectious agents in modern
obstetrics. The study objectives were to: (i) compare
the performance of AF culture and PCR/ESI-MS in
identifying MIAC in patients with PTL; (ii) assess the
magnitude of intra-amniotic inflammation in patients
with MIAC identified by PCR/ESI-MS; and (iii)
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examine the relationship between MIAC detected by
PCR/ESI-MS and adverse pregnancy outcome.
Materials and methods
Study Population
A cohort study was conducted by searching the clin-
ical database and bank of biologic samples of Wayne
State University, the Detroit Medical Center, and the
Perinatology Research Branch of the Eunice Kennedy
Shriver National Institutes of Child Health and
Human Development (NICHD) (Detroit, MI), to
identify patients with a diagnosis of spontaneous
PTL. Patients were included if they met the follow-
ing criteria: (i) had a singleton gestation; (ii) pre-
sented with PTL; and (iii) had a transabdominal
amniocentesis performed between 20 and 35 weeks
of gestation with microbiologic studies. Patients were
excluded from the study if: (i) rupture of the chor-
ioamniotic membranes occurred before AF collec-
tion; or (ii) a chromosomal or structural fetal
anomaly was present. Perinatal mortality was
defined as the occurrence of fetal or neonatal death.
All patients provided written informed consent; the
use of biologic specimens and clinical data for research
purposes was approved by the Institutional Review
Boards of NICHD and Wayne State University.
Sampling Procedures
Patients with preterm labor and intact membranes
who underwent transabdominal ultrasound-guided
amniocentesis for evaluating possible MIAC (within
the standard of care at Hutzel Women’s Hospital,
Detroit, Michigan) were eligible for the study. AF
was immediately transported in a capped sterile syr-
inge to the clinical laboratory where it was cultured
for aerobic and anaerobic bacteria, including genital
mycoplasmas. Evaluation of white blood cell (WBC)
count, glucose concentration, and Gram stain of AF
were also performed shortly after collection. AF not
required for clinical assessment was centrifuged for
10 min at 4°C shortly after the amniocentesis, and
the supernatant was aliquoted and stored at 70°C
until analysis. The presence of intra-amniotic inflam-
mation was assessed by determination of AF inter-
leukin-6 (IL-6) concentration by ELISA. AF IL-6
concentrations were determined for research pur-
poses, and such results were not used in patient
management.
Detection of Microorganisms with Cultivation and
Molecular Methods
AF was analyzed using cultivation techniques (aero-
bic, anaerobic, and genital mycoplasmas) as well as
PCR/ESI-MS (Ibis Technology - Athogen, Carlsbad,
CA, USA). Briefly, DNA was extracted from 300 lL
of AF using a method that combines bead-beating
cell lysis with a magnetic-bead-based extraction
method.135,136 The extracted DNA was amplified by
the previously described broad bacteria and candida
(BAC) detection assay according to the manufac-
turer’s instructions. PCR/ESI-MS can identify 3400
bacteria and 40 Candida spp., which are represented
in the platform’s signature database.112,114,137 For
viral detection, the nucleic acids were extracted from
300 lL of AF using a method that combined chemi-
cal lysis with a magnetic-bead based extraction
method. The extracted RNA/DNA was amplified on
the broad viral assay according to the manufacturer’s
instructions. In the 8 wells, there were fourteen pri-
mer pairs used to detect the following viruses: Herpes
simplex virus 1 (HHV-1), Herpes simplex virus 2 (HHV-
2), Varicella-zoster virus (HHV-3), Epstein-Barr virus
(HHV-4), Cytomegalovirus (HHV-5), Kaposi’s sarcoma-
associated herpes virus (HHV-8), human adenoviruses,
human enteroviruses, BK polyomavirus, JC polyomavirus,
and Parvovirus B19.137
After PCR amplification, 30-lL aliquots of each
PCR product were desalted and analyzed via electro-
spray ionization time-of-flight mass spectrometer
(ESI-MS) as previously described.112,116 The presence
of microorganisms was determined by signal process-
ing and triangulation analysis of all base composition
signatures obtained from each sample and compared
to a database. Along with organism identification,
the ESI-MS analysis includes a Q-score and level of
detection (LOD). The Q-score, a rating between 0
(low) and 1 (high), represents a relative measure of
the strength of the data supporting identification;
only Q-scores ≥ 0.90 were reported for the BAC
spectrum assay.132 The LOD describes the amount of
amplified DNA present in the sample: this is calcu-
lated with reference to an internal calibrant, as pre-
viously described108 and is reported herein as
genome equivalents per PCR well (GE/well). The
bacterial/viral genome load per mL of AF (GE/mL) is
equal to the GE/well multiplied by 133.33. The sen-
sitivity (LOD) of the assay for the detection of bacte-
ria in blood is, on average, 100 CFU/mL (95% CI, 6–
600 CFU/mL).114 A comparison of detection limits
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between blood and AF show that the assays have
comparable detection limits (100 CFU/mL). The sen-
sitivity (LOD) for the broad viral in plasma ranges
from 400 copies/mL to 6600 copies/mL.138 A com-
parison of detection limits between AF and plasma
was performed by spiking known amounts of a DNA
virus (HHV-5) and an RNA virus (human enterovi-
rus) into AF and plasma. Detection limits in AF were
similar to plasma, ranging from approximately 800
to 1600 copies/mL (depending upon the specific
microorganism).
Determination of IL-6 in Amniotic Fluid
AF concentrations of IL-6 were determined to assess
the magnitude of the intra-amniotic inflammatory
response. We used a sensitive and specific enzyme
immunoassay obtained from R&D Systems (Minne-
apolis, MN, USA). Briefly, the immunoassay utilized
the quantitative sandwich enzyme immunoassay
technique, and the concentrations were determined
by interpolation from the standard curves. The inter-
and intra-assay coefficients of variation for IL-6 were
8.7 and 4.6%, respectively. The detection limit of
the IL-6 assay was 0.09 pg/mL.
Clinical Definitions
Preterm labor was diagnosed by the presence of at
least two regular uterine contractions every 10 min
associated with cervical changes in patients with a
gestational age between 20 and 36 6/7 weeks. Pre-
term delivery was defined as birth prior to the 37th
week of gestation. Acute histologic chorioamnionitis
was diagnosed based on the presence of neutrophils
in the chorionic plate and/or chorioamniotic mem-
branes.139–141 Intra-amniotic inflammation was diag-
nosed when IL-6 AF concentration was ≥ 2.6 ng/
mL.41,142 MIAC was defined according to the results
of AF culture and PCR/ESI-MS analysis.99,101,143,144
Intra-amniotic infection was defined as a combination
of MIAC with intra-amniotic inflammation.
Statistical Analysis
The Kolmogorov–Smirnov test and visual plot
inspection were used to assess the normality of con-
tinuous data distributions. Spearman’s nonparamet-
ric correlation coefficients were calculated. The
Kruskal–Wallis and Mann–Whitney U-tests were
used to test for differences in arithmetic variable dis-
tributions. The chi-square test or Fischer’s exact test
was used to test for differences in proportions, as
appropriate. Quantile regression models were fit to
test for median differences adjusting for potential
confounders, including gestational age and cervical
dilatation at amniocentesis. Kaplan–Meier survival
curves were plotted, and the Mantel-Haenszel
log-rank test was used to test for differences in time-
to-spontaneous preterm delivery. Logistic and Cox
proportional hazards regression models were fit to
examine magnitudes of association. A cutoff for clas-
sifying PCR/ESI-MS results according to the micro-
bial inoculum size (genome copies/well) in each
sample was selected upon inspection of a receiver
operating characteristic (ROC) curve for the identifi-
cation of intra-amniotic inflammation among
patients with detectable gene copies by PCR/ESI-MS.
For all analyses, a two-tailed P value < 0.05 was
considered significant. SPSS v.15.0 (SPSS, Chicago,
IL, USA) was used to analyze the data.
Results
Characteristics of the Study Population
Baseline characteristics of the study population are
displayed in Table I. The median [interquartile
range (IQR)] gestational age at amniocentesis was
30 (IQR: 25–32) weeks. The median gestational age
at delivery was 34 (IQR: 27–37) weeks. Extraplac-
ental membranes were examined for 92% (131/
142) of the study population. The prevalence of
acute histologic chorioamnionitis was 41% (53/
131).
The Prevalence of MIAC and Microbial Diversity
The prevalence of MIAC based on a positive AF cul-
ture was 7% (10/142). PCR/ESI-MS detected ampli-
fied DNA in 21% (30/142) of the AF samples
(Table I). Upon inspection of a ROC curve for the
identification of intra-amniotic inflammation (IL-
6 ≥ 2.6 ng/mL) among patients with detectable DNA
from bacteria and/or virus using PCR/ESI-MS
(Fig. 1), results were classified according to microbial
burden as positive or negative. Positive tests had 17
or more GE/well, whereas negative tests had fewer
than 17 GE/well, or genomic material was unde-
tected. Figure 2 shows a Venn diagram describing
the combined results of AF culture and PCR/ESI-MS.
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Seven of the 17 patients with positive PCR/ESI-MS
(>17 GE/well) had positive AF cultures.
For each patient with detectable genomic material
by PCR/ESI-MS or positive AF cultures, the microor-
ganisms identified, concentrations of inflammatory
markers in amniotic fluid, gestational age at deliv-
ery, and the presence or absence of acute histologic
chorioamnionitis, are shown in Table II. The most
frequent microorganism identified by PCR/ESI-MS
was Ureaplasma parvum (instead of Ureaplasma urea-
lyticum, which was the most common microorganism
identified by standard AF culture). Fusobacterium nu-
cleatum, Gardnella vaginalis, Mycoplasma hominis, and
Acinetobacter junii were only detected by PCR/ESI-
MS. Two patients (1.4%) had a positive viral assay
for human enterovirus using PCR/ESI-MS. One of
these two patients also had genomic material consis-
tent with Acinetobacter junii.
The Relationship Between the Presence and
Burden of Microorganisms in the Amniotic Fluid
and Intra-Amniotic Inflammation
The microbial inoculum size, expressed as GE/well,
was significantly correlated with AF concentration of
IL-6 and the AF WBC count [Spearman’s rho
(q) = 0.63, P < 0.001 and q = 0.67, P < 0.0001].
Exclusion of patients with positive AF cultures did
not alter these findings [AF IL-6: q = 0.61 P = 0.002
and AF WBC: q = 0.51, P = 0.01].
Figure 3a,b display AF concentrations of IL-6
and AF WBC count, respectively, among four
study groups according to results of PCR/ESI-MS
and AF cultures. The first group had a positive AF
culture and a positive PCR/ESI-MS (≥17 GE/well)
(n = 7). The second group included patients with
positive PCR/ESI-MS (≥17 GE/well) who had nega-
tive AF cultures (n = 10). The third and fourth
groups included patients with negative PCR/ESI-
MS (<17 GE/well) who had negative (n = 122) or
positive (n = 3) AF cultures, respectively.
Among patients with positive PCR/ESI-MS (≥17
GE/well), there was no significant difference in the
median AF IL-6 concentration between those with
(n = 7) and without (n = 10) positive AF cultures
[185.4 (IQR: 30–275.4) versus 87 (IQR: 11.3–
264) ng/mL, P = 0.43] (Fig. 3a). The median AF
IL-6 concentration was significantly higher in
patients with positive PCR/ESI-MS results (≥ 17
GE/well) and negative AF cultures than in: (i)
women with positive AF cultures and negative
PCR/ESI-MS results (n = 3); and (ii) patients with
negative AF cultures and negative PCR/ESI-MS
(n = 122) [87 (IQR: 11.3–264) ng/mL versus 0.2
(IQR: 0.2–0.3), and 1.1 (IQR: 0.7– 5) ng/mL,
respectively, P < 0.001]. However, the median AF
IL-6 concentration was significantly higher in
patients without MIAC (by AF culture and PCR/
Table I Maternal Characteristics and Demographic Data of the
Study Population
Median (IQR) or % (n/N)
Maternal age (years) 23 (20–26.3)
Body mass index (kg/m2) 24 (21–30)
Cervical dilatation at admission (cm) 3 (2.0–3.5)
AF glucose (mg/dL) 25 (19–31)
AF white blood cell count (cells/mm3) 2 (0–12)
GA at amniocentesis (weeks) 30 (25–32)
GA at delivery (weeks) 34 (27–37)
Birth weight (grams) 2190 (930–2700)
AF culture positive 7 (10/142)
Detection of bacteria and/or
virus genome by PCR/ESI-MS
21 (30/142)
Positive PCR-ESI-MS (GE/well ≥ 17) 12 (17/142)
AF, amniotic fluid; GA, gestational age; GE/well, genome equiva-
lent per PCR; IQR, interquartile range; PCR, polymerase chain
reaction; ESI-MS, electrospray ionization mass spectrometry.
Fig. 1 Receiver operator characteristic curve analysis of PCR/ESI-MS
genome equivalents per PCR well (GE/well) results for the identification
of intra-amniotic inflammation (amniotic fluid IL-6 ≥ 2.6 ng/mL) among
patients with detectable DNA of bacteria and/or viruses. A GE/well ≥17
had an area under the ROC curve of 0.93 (95% CI 0.83–1.0; P < 0.001).
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ESI-MS) than in patients with positive AF cul-
ture and negative PCR/ESI-MS (P = 0.009)
(Fig. 3a).
Differences in the median AF WBC count
between the four groups were consistent with those
of AF IL-6. There were no differences in the med-
ian WBC count between patients with positive
PCR/ESI-MS (≥ 17 GE/well) who had positive
(n = 7) or negative (n = 10) AF cultures [490 (IQR:
50–1920) versus 185 (IQR: 0.7–1043) cell/mm3,
P = 0.28]. The median AF WBC count among these
two study groups was significantly greater than the
median AF WBC count of the two study groups
with negative PCR/ESI-MS (<17 GE/well), irrespec-
tive of the AF culture results (P < 0.0001) (Fig. 3b).
Differences in the median AF IL-6 and WBC con-
centrations between the four groups were consis-
tent both in direction and statistical significance
when fitting a quantile regression model to adjust
for potential confounders, including gestational age
and cervical dilatation at amniocentesis [data not
shown].
Figure 4a shows the prevalence of intra-amniotic
inflammation (IL-6 ≥ 2.6 ng/mL) according to the
results of AF culture and PCR/ESI-MS. Intra-amni-
otic inflammation was diagnosed in 70% (n = 7/10)
and 94% (n = 16/17) of patients with positive AF
culture and a positive PCR/ESI-MS (≥17 GE/well)
results, respectively. Accordingly, these patients had
intra-amniotic infection (i.e. MIAC and intra-amni-
otic inflammation).
All but one patient with a positive PCR/ESI-MS
(≥ 17 GE/well) and a negative AF culture had intra-
amniotic inflammation [90%, (9/10)]. These patients
were significantly more likely to have intra-amniotic
inflammation than women with negative tests,
adjusting for gestational age and cervical dilatation
at amniocentesis [odds ratio (OR) 12.2, 95% confi-
dence interval (CI) 1.5–97] (Table III). None of the
three women with positive AF cultures and negative
PCR/ESI-MS had intra-amniotic inflammation; 32%
(39/122) of the patients with negative results for
both tests (AF culture and PCR/ESI-MS), which are
considered ‘sterile’ samples, had intra-amniotic
inflammation (Fig. 4a).
The Relationship Between Detectable
Microorganisms in the Amniotic Fluid and Acute
Histologic Chorioamnionitis
Figure 4b shows the prevalence of acute histologic
chorioamnionitis among the four groups, according
to the results of PCR/ESI-MS and AF culture. Each
of the seven patients with positive AF cultures and
positive PCR/ESI-MS results (GE/well ≥ 17) had
acute histologic chorioamnionitis. This lesion was
diagnosed in 70% (7/10) of patients with a positive
PCR/ESI-MS (≥ 17 GE/well) and negative AF cul-
tures. These patients were significantly more likely
to have acute histologic chorioamnionitis than
women with negative tests, adjusting for gestational
age and cervical dilatation at amniocentesis [OR 5.1,
Fig. 2 Bacteria and viruses detected in
amniotic fluid of patients with preterm labor
using standard cultivation techniques versus
PCR/ESI-MS. Amniotic fluid culture includes
routine cultivation techniques for bacteria
(aerobes, anaerobes, and genital
mycoplasmas). PCR/ESI-MS refers to broad-
range polymerase chain reaction (PCR) and
electrospray ionization time-of-flight mass
spectrometry (ESI-MS).
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Table II Amniotic Fluid Inflammatory Profile, Delivery Information, Placenta Pathology, and Perinatal Mortality in Patients with Microbial Invasion of
Patient
number Group
Amniotic Fluid Culture and PCR/ESI-MS Results Amniotic fluid (AF) test results
AF culture PCR/ESI-MS bacteria
GE/well
bacteria
PCR/ESI-MS
viruses
GE/well
viruses
AF-IL6
(ng/mL)
Intra-amniotic
inflammation
AF
Gram
stain
1 Positive
AF Culture
and positive
PCR/ESI-MS
(n = 7)
Ureaplasma
spp
Ureaplasma parvum 575 Not detected 0 29.8 Yes Neg
2 Candida
albicans
Candida albicans 215 Not detected 0 201.3 Yes Neg
3 Ureaplasma
spp
Ureaplasma parvum
Fusobacterium
nucleatum
129
6
Not detected 0 275.5 Yes Pos
4 Ureaplasma
spp
Ureaplasma parvum 1795 Not detected 0 86 Yes Neg
5 Streptococcus Gardnerella vaginalis
Mycoplasma hominis
69
83
Not detected 0 185.5 Yes Neg
6 Ureaplasma
urealyticum
Ureaplasma urealyticum 1484 Not detected 0 9.9 Yes Pos
7 Bacteroides Fusobacterium nucleatum 20 Not detected 0 517.8 Yes Neg
8 Negative AF
culture and
GE/Well ≥ 17
(n = 10)
Negative Not detected 0 Human
Enterovirus
>1000 6.0 Yes Neg
9 Negative Fusobacterium nucleatum 27 Not detected 0 46.8 Yes Neg
10 Negative Ureaplasma urealyticum 768 Not detected 0 265.5 Yes Neg
11 Negative Acinetobacter junii 68 Human
Enterovirus
24 77.7 Yes Neg
12 Negative Acinetobacter junii 41 Not detected 0 0.28 No Neg
13 Negative Sneathia species 280 Not detected 0 290.7 Yes Pos
14 Negative Pseudomonas
entomophila/putida
23 Not detected 0 13.1 Yes Neg
15 Negative Ureaplasma parvum 571 Not detected 0 118.5 Yes Neg
16 Negative Candida albicans 57 Not detected 0 96.3 Yes Pos
17 Negative Sneathia species 152 Not detected 0 263.3 Yes Pos
18 Negative AF
culture and
GE/Well < 17
(n = 13)
Negative Aeromonas caviae 3 Not detected 0 0.6 No Neg
19 Negative Acinetobacter junii 14 Not detected 0 1.6 No Neg
20 Negative Moraxella osloensis 3 Not detected 0 1.0 No Neg
21 Negative Staphylococcus aureus 5 Not detected 0 0.6 No Neg
22 Negative Staphylococcus aureus 7 Not detected 0 1.6 No Neg
23 Negative Acidovorax sp. 11 Not detected 0 0.4 No Neg
24 Negative Streptococcus species 3 Not detected 0 1.0 No Neg
25 Negative Lactobacillus
acidophilus/crispatus
5 Not detected 0 2.3 No Neg
26 Negative Ureaplasma parvum 8 Not detected 0 0.2 No Neg
27 Negative Gardnerella vaginalis 5 Not detected 0 16.5 Yes Neg
28 Negative Ureaplasma parvum 4 Not detected 0 0.2 No Neg
29 Negative Staphylococcus aureus 8 Not detected 0 51.8 Yes Neg
30 Negative Pantoea dispersa 3 Not detected 0 0.9 No Neg
31 Positive AF
culture and
Negative
PCR/ESI-MS
(n = 3)
Ureaplasma
urealyticum
Not detected 0 Not detected 0 0.2 No Neg
32 Ureaplasma
urealyticum
Not detected 0 Not detected 0 0.4 No Neg
33 Staphylococcus
aureus
Not detected 0 Not detected 0 0.2 No Neg
GA, gestational age; AF, amniotic fluid; WBC, white blood cells; IL-6, interleukin-6; PCR, polymerase chain reaction; ESI-MS, electrospray
Severity of acute histologic chorioamnionitis: Stage 1 – Early: Acute Subchorionitis/Chorionitis; Stage 2 – Intermediate: Acute Chorioamnionitis;
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the Amniotic Cavity According to Amniotic Fluid Cultures versus GE/Well Results Using PCR/ESI-MS
lts Delivery information Histologic Placenta Lesions
Perinatal
mortality
AF
Gram
stain
AF
Glucose
AF
WBC
GA at
amniocentesis
(weeks)
GA at
delivery
(weeks)
Interval-
amniocentesis-to
delivery (days)
Acute
histologic
chorioamnionitis
Severity of
histologic
chorioamnionitis
Neg 10 490 32.4 32.6 1 Yes 2 No
Neg 10 2160 26.3 26.4 1 Yes 3 No
Pos ND 50 24.9 26.0 8 NI NI Yes
Neg 10 500 32.9 33.0 1 Yes 2 No
Neg 10 1920 31.7 31.9 1 Yes 3 No
Pos 20 10 32.1 32.7 4 Yes 2 No
Neg 10 295 22.6 22.6 0 Yes 3 Yes
Neg 21 0 21.6 21.7 1 No No Yes
Neg 24 1 25 25.7 5 Yes 4 Yes
Neg 11 357 20.4 20.4 0 Yes 3 Yes
Neg 20 0 24.6 24.7 1 Yes 1 No
Neg 30 2 29.1 39.9 75 No No No
Pos 10 440 26 26.0 0 Yes 3 No
Neg 17 13 33.9 33.9 0 No No No
Neg 10 2750 26.7 27.0 2 Yes 3 No
Pos 10 1292 32.4 32.6 1 Yes 2 No
Pos 10 960 23.6 23.6 0 Yes 4 Yes
Neg ND 10 30.1 30.1 0 No No No
Neg 30 3 32.1 33.6 10 No No No
Neg 29 8 32.4 39.9 52 No No No
Neg 30 0 33.3 37.6 30 No No No
Neg 10 0 34.1 34.9 5 No No No
Neg 29 20 27 27.3 2 No No No
Neg 10 0 34.1 36.9 19 Yes 2 No
Neg 25 1 28.1 39.7 81 Yes 2 No
Neg 31 0 22.3 25.3 21 Yes 3 No
Neg 52 0 28.4 35.4 49 No No No
Neg 22 2 26.4 27.0 4 No No No
Neg 25 5 29.7 33.9 29 No No No
Neg 54 2 27.4 28.3 6 No No No
Neg 24 0 34.6 35.1 4 Yes 1 No
Neg 19 2 29.1 39.3 71 No No No
Neg 20 225 31 36.9 41 No No No
ionization mass spectrometry; GE/well, genome equivalent per PCR; NI, not information.
Stage 3 – Necrotizing Chorioamnionitis; Stage 4 – Subacute Chorioamnionitis.
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95% CI 1.01–26, respectively] (Table III). One of the
three women with a positive AF culture and a nega-
tive PCR/ESI-MS had mild acute histologic chorio-
amnionitis (stage 1 subchorionitis/chorionitis)
(Fig. 4b).
The observations described in the previous para-
graph, combined with the parameters assessing
intra-amniotic inflammation, reveal that a positive
AF culture among patients with negative PCR/ESI-
MS results likely reflect either early-phase microbial
invasion, in which an inflammatory response is not
detectable, or contamination of the specimen (false-
positive culture).
The Presence of Microorganisms in the Amniotic
Fluid by Molecular Techniques and the Risk of
Spontaneous Preterm Delivery
Table IV presents the positive predictive values (PPV)
of AF culture and positive PCR/ESI-MS (≥ 17 GE/
well) for the identification of patients who delivered
spontaneously prior to 37 and 32 weeks, respectively.
The PPV of a positive AF culture for spontaneous
delivery before 37 and 32 weeks was 90 and 66.7%,
respectively. In contrast, the PPV of a positive PCR/
ESI-MS (≥ 17 GE/well) was 94.1 and 91.7% for the
same outcomes.
Presence and Burden of Microorganisms in
Amniotic Fluid and the Interval to Spontaneous
Preterm Delivery
Kaplan–Meier survival estimates, censoring patients
in whom labor was induced for maternal or fetal indi-
cations, showed that the amniocentesis-to-delivery
interval was significantly shorter in patients with posi-
tive PCR/ESI-MS results (≥ 17 GE/well) and negative
AF culture than in patients with negative results for
both tests [1 (IQR: <1–2) days versus 25 (IQR:
5–51) days; P = 0.002]. There were no significant dif-
ferences in the median amniocentesis-to-delivery
interval between patients who had positive PCR/ESI-
MS results (≥ 17 GE/well) with negative AF cultures
[1 (IQR: <1–2) days] and those patients with positive
findings for both tests [1 (IQR: 1–8) days] (P = 0.6)
(Fig. 5).
Figure 6 shows a forest plot of the hazard ratios
(HR) describing the relative risks of spontaneous
preterm delivery (sPTD) for patients with positive
PCR/ESI-MS (≥ 17 GE/well) and/or AF cultures
(a) (b)
Fig. 3 Markers of infection in amniotic fluid according to the results of standard AF culture and PCR/ESI-MS. Amniotic fluid concentrations of
interleukin-6 (Panel a) and white blood cell (WBCs) count (Panel b) as a function of PCR/ESI-MS and AF culture results. There was no significant
difference in the median AF IL-6 concentration and WBC count between patients with a negative AF culture and a positive PCR/ESI-MS (GE/well
≥17) and those with a positive AF culture and positive PCR/ESI-MS (P = 0.43 and 0.28, respectively). Among patients with a negative AF culture,
those with a positive PCR/ESI-MS had a significantly higher median AF IL-6 concentration and WBC count than patients with both tests negative
(P < 0.001 and P = 0.02, respectively). The median AF IL-6 concentration in patients with a positive AF culture and negative PCR/ESI-MS (GE/well
< 17) was always < 2.6 ng/mL.
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compared to with negative tests, adjusted for gesta-
tional age at amniocentesis and cervical dilatation.
The risks (i.e., hazard) of sPTD at <37 weeks and,
separately, <32 weeks were significantly greater
among patients with positive PCR/ESI-MS results
(≥ 17 GE/well), both with and without positive AF
cultures, when compared to women with negative
tests [sPTD <37: AF+, HR 3.9 (95% CI 1.7–9.1) and
AF-, HR 3.8 (95% CI 1.8–8.1); sPTD <32: AF+, HR
3.3 (95% CI 1.1–10.1) and AF-, HR 5.2 (95% CI 2–
13.4)].
Detection of Microbial Invasion of the Amniotic
Cavity Using Cultivation and Molecular
Techniques and the Risk of Perinatal Death
The prevalence of perinatal death (fetal and neonatal
death) differed significantly between the four study
groups defined by the results of AF culture and
PCR/ESI-MS (P = 0.03) (Fig. 7). Twenty percent of
perinatal death (4/19) occurred in the 7% (10/142)
of women with positive PCR/ESI-MS and negative
AF culture results. Offspring of these women were
at a fivefold greater risk of perinatal mortality than
those of women with negative AF culture and nega-
tive PCR/ESI-MS results (OR 5.6; 95% CI 1.4–22).
There was no difference in the rate of perinatal
death for the offspring of women with positive PCR/
ESI-MS according to the results of AF culture [posi-
tive culture 29% (2/7) versus negative culture 40%
(4/10); P = 1.0].
Comment
Principal findings of the study were as follows: (i)
the prevalence of MIAC in patients with preterm
labor and intact membranes was 7% using standard
cultivation techniques and 12% using PCR/ESI-MS;
(ii) patients with positive PCR/ESI-MS (≥17 GE/well)
and negative AF cultures had higher rates of
intra-amniotic inflammation and acute histologic
chorioamnionitis, a shorter interval to delivery, and
their offspring were at greater risk of perinatal mor-
tality than patients with negative results for both
(a)
(b)
Fig. 4 Prevalence of intra-amniotic
inflammation (Panel a) and acute histologic
chorioamnionitis (Panel b) according to the
results of PCR/ESI-MS and amniotic fluid
cultures. Intra-amniotic inflammation was
diagnosed in 70% (n = 7/10) and 94% (n = 16/
17) of patients with a positive AF culture and
positive PCR/ESI-MS (≥17 GE/well) results,
respectively. Patients with positive PCR/ESI-
MS (GE/well ≥ 17) and negative AF culture
had a 70% prevalence of acute histologic
chorioamnionitis of 70% (7/10). In contrast,
the prevalence of acute histologic
chorioamnionitis in patients with negative AF
culture and negative PCR/ESI-MS (GE/well
< 17) was 35% (39/112).
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tests; (iii) there were no differences in these factors
when comparing patients with positive PCR/ESI-MS
(≥17 GE/well) who had positive AF cultures to those
with negative AF cultures; and iv) genomic material
from viruses was detected in two patients [1.4% (2/
142)]. Altogether, these findings indicate that PCR/
ESI-MS can be used as a rapid test to diagnose
MIAC.
Microbial Invasion of the Amniotic Cavity
A key transition in human life is the emergence from
a sterile to a non-sterile environment at the time of
birth.145 The AF is sterile under normal circumstances
as demonstrated by studies with cultivation and mole-
cular methods.43,62,146–154 In contrast, 25–40% of
patients with preterm labor and intact membranes
who deliver preterm have evidence of
MIAC,7–43,155,156 whereas 50–75% of women with
pre-labor rupture of membranes (PROM) have
MIAC.25,53,101,156
The prevalence of MIAC is a function of the obstet-
rical circumstances that prompted investigation of the
microbial state in the amniotic cavity. For example,
the earlier the gestational age at presentation with
preterm labor with intact membranes or preterm
PROM, the higher the frequency of
MIAC.20,26,41,99,101,157–159 In PROM, the frequency of
MIAC increases from 39% (24/61) in patients not in
labor to 75% (36/48) with the onset of spontaneous
preterm labor (P = 0.0004).53 These data were
obtained before routine administration of antibiotics
to patients with preterm PROM and are the basis for
the clinical view that the onset of labor in these
women is frequently related to subclinical intra-amni-
otic infection.
The prevalence of MIAC ranges from 10–12%
in patients with preterm labor and intact mem-
branes9–16,20–27,30–37,61 to 51% in pregnant women
diagnosed with acute cervical insufficiency
(Table V).160–163 These cultivation-based studies
provided strong evidence for the involvement of
microorganisms in pregnancy complications. Yet,
cultivation techniques can only provide a minimum
estimate of the prevalence of MIAC.39,99,156,164165
Molecular Techniques for the Identification of
Microorganisms
Molecular detection of microorganisms has been pro-
posed to be a ‘diagnostic tool for the new millen-
nium’.85,166,167 In the United States 5 million cases of
infectious disease-related illness are reported annu-
ally, and many more are considered to be undiag-
nosed.168 Accordingly, the application of molecular
testing to acute care settings is of major interest.
Identification and culture of bacteria from AF has
been considered the ‘gold standard’ for the diagnosis
of MIAC.10,11,15,16,19,24,42,50–66 However, successful
cultivation of an organism requires knowledge of
the conditions necessary to support growth of spe-
cific microorganisms.169 These conditions are often
Table III Magnitudes of Association Among Combined Test Results and Intra-Amniotic Inflammation and acute Histologic Chorioamnionitis
Intra-amniotic inflammation Acute Histologic chorioamnionitis
OR 95% CI OR 95% CI
Unadjusted
PCR/ESI-MS (+) – AF (+) 31.7 1.5 691 25.8 1.1 591
PCR/ESI-MS (+) – AF () 13.4 2.1 85 4.3 1.1 17
PCR/ESI-MS () – AF (+) 0.3 0.01 9 1.2 0.1 13
PCR/ESI-MS () – AF () 1 Reference 1 Reference
Adjusteda
PCR/ESI-MS (+) – AF (+) 47.8 1.8 >999 32.6 1.3 788
PCR/ESI-MS (+) – AF () 12.2 1.5 97 5.1 1.01 26
PCR/ESI-MS () – AF (+) 0.9 0.02 35 1.7 0.2 20
PCR/ESI-MS () – AF () 1 Reference 1 Reference
AF, amniotic fluid; GE/well, genome equivalent per well; PCR, polymerase chain reaction; ESI-MS, electrospray ionization mass spectrometry.
aAdjusted for cervical dilation and gestational age at amniocentesis; Firth’s penalized maximum likelihood estimation was performed where
necessary to resolve separation issues.
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unknown, rendering standard techniques inadequate
in detecting many organisms implicated in human
diseases.170–174 For example, Treponema pallidum has
remained difficult to culture for decades.175,176 In
addition, cultivation methods are prone to false-neg-
ative results when antibiotics are administered
before the biological fluid is obtained for culture.67–
75 Moreover, the results generally take days and are
often not available in time to make informed clinical
decisions (e.g., antibiotic administration).
The realization that only a small fraction of the
microbial world is readily culturable in clinical
laboratories177–181 prompted the development of
PCR-based diagnostic techniques for infectious dis-
eases.83–88 The advantages of molecular techniques
are that they allow broad-spectrum microbial detec-
tion, evaluation of emerging novel infections, assess-
ment of antimicrobial resistance profiling,85,103,105
virulence factors,85,104 and their relatively low
cost.85 These methods have been used to identify
agents responsible for conditions previously consid-
ered to be of unknown etiology (e.g., Tropheryma
whipplei, the agent of Whipple’s disease,182,183 Myco-
bacterium genavense, a cause of disseminated infections
in AIDS patients,184 Ehrlichia chaffeensis, an agent of
human tick-borne monocytic ehrlichiosis,185 and
Bartonella henselae, the agent of Trench fever).186–188
However, implementation of PCR techniques in clini-
cal practice has not been easy. Bacteria, viruses, and
fungi must be investigated using separate assays, and
the time required to obtain results has been lengthy.
Broad-Range PCR with ESI-MS for the Rapid
Detection of Microorganisms
Broad-range PCR methods for the detection of bacte-
ria are based on the premise that the 16S rRNA gene
is evolutionarily conserved in bacterial species.189,190
The detection of this gene in a sterile biologic fluid
(such as AF) indicates the presence of bacteria. This
approach has been used by many investiga-
tors to identify bacteria in AF using species-
specific34,39,42,65,89,92–97,100,191–195 or broad-range
PCR.90–92,99,101,143,144,196–199 Most of the studies
Table IV Positive Predictive Value (PPV) of GE/Well Reported by PCR/ESI-MS and AF Cultures for the Identification of Adverse Pregnancy
Outcomes
sPTD
< 37 weeks
sPTD
< 32 weeks
Delivery within 7 days of
amniocentesis
Delivery within 2 days
of amniocentesis
Prevalence 79.6% (113/142) 52.6% (50/95) 37.3% (53/142) 21.1% (30/142)
PPV of positive culture 90% (9/10) 66.7% (4/6) 70% (7/10) 50% (5/10)
PPV of PCR/ESI/MS (GE/well ≥ 17) 94.1% (16/17) 91.7% (11/12) 88.2% (15/17) 76.5% (13/17)
AF, amniotic fluid; PCR, polymerase chain reaction; ESI-MS, electrospray ionization mass spectrometry; GE/well, genome equivalent per PCR.
Fig. 5 Kaplan–Meier survival analysis of
amniocentesis-to-delivery interval (days)
according to amniotic fluid cultures and PCR/
ESI-MS results. Patients in whom labor was
induced were censored and are represented
by crosses. Among patients with negative
amniotic fluid cultures, the amniocentesis-to-
delivery interval was significantly shorter in
patients with a positive PCR/ESI-MS than in
those with a negative PCR/ESI-MS result [1
(IQR: < 1–2) days versus 25 (IQR: 5–51) days;
P = 0.002]. There were no significant
differences in the median amniocentesis-to-
delivery interval between patients who had a
positive PCR/ESI-MS with a negative AF culture
[1 (IQR: < 1–2) days] and patients with both
tests positive [1 (IQR: 1–8) days] (P = 0.6).
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have shown that broad-range PCR assays and
specific assays are superior to culture in the
detection of microorganisms in the
AF.90–92,99,101,143,144,196–199 Yet, until recently, these
techniques have remained research procedures
because the time required to obtain results has pre-
cluded their use as a point-of-care test.
An advantage of the PCR/ESI-MS technology
over conventional PCR methods using broad prim-
ers is that mass spectrometry allows the rapid iden-
tification of the organism.109,111 PCR/ESI-MS results
can be obtained within 8 hours.106,112,113 The PCR/
ESI-MS system is able to quantify the amount of
genomic material present in a biologic sam-
ple.108,109 Genome quantification is useful in clini-
cal circumstances to monitor therapeutic effects.
This can also be used in selecting the route of
delivery (vaginal versus cesarean) in cases of HIV
infection.200–206 Other examples in which this
approach has been valuable include the diagnosis/
identification of visceral leishmaniasis,207–209 infec-
tious mononucleosis,210–212 and pneumococcal
pneumonia.213,214
PCR/ESI-MS technology uses the concept of ‘trian-
gulation’ to distinguish among microorganisms. This
term refers to taking measurements from multiple
loci distributed across the microbial genome.108,109
Subsequently, ESI-MS is used to rapidly determine
the precise mass-to-charge ratio of the fragments
amplified based upon their nucleotide composition
to create a signature that allows for the identification
of a large number of microorganisms109,112 at the
genus and species levels.112,116,120–122,131
Broad-Range PCR with ESI-MS for the Detection
of Microorganisms in Amniotic Fluid Intra-
Amniotic Infection
The identification of bacteria in AF is a pathological
finding (‘microbial invasion of the amniotic cav-
ity’).18,24,40,57,59,60,62,143,144,160,165,215–219 The distinc-
tion between such invasion and infection is
predicated on the host response to the invading
microorganism(s).23,42,43,60,149,156,157,165,216,217,219–235
Thus, intra-amniotic infection refers to the
combination of MIAC with intra-amniotic inflamma-
tion.40,41,43,162,165,218,234,236–238 In this study, MIAC
was diagnosed by PCR/ESI-MS in 12% (n = 17/142)
of the study population, and 94% (n = 16/17) of
these patients exhibited a host inflammatory
response consistent with intra-amniotic infection
(AF IL-6 ≥ 2.6 ng/mL). Seventy percent (n = 7/10)
of patients with positive amniotic fluid cultures had
such a host response, although each of the seven
cases with both tests positive met the criteria for
intra-amniotic infection. Accordingly, use of PCR/
ESI-MS resulted in a two-fold greater prevalence of
intra-amniotic infection (5% vs 11%).
Detection of Viruses in the Amniotic Cavity
The role of viral infection in spontaneous preterm
labor has not been rigorously examined. Previous
studies using PCR-based methods have shown con-
flicting results describing the prevalence of viral inva-
sion of the amniotic cavity (VIAC), ranging from non-
detectable to as high as 6.4%.151–153,239–241 In this
study, we used PCR/ESI-MS to detect multiple organ-
isms in the same sample (viruses and bacteria).109
However, only two patients (1.4%) had positive
results for Enterovirus. Gervasi et al.,154 using specific
PCR assays for a panel of viruses, reported that the
prevalence of VIAC during the second trimester was
2.2%. In that study, AF samples were obtained from
asymptomatic patients during the second trimester.
The presence of viral nucleic acid in AF was not
associated with detectable inflammation as reflected
by AF WBC count, glucose and IL-6 concentrations
between patients with and without VIAC.154 Simi-
larly, Baschat et al.153 suggested that the isolation of
viruses in the amniotic cavity was not associated with
adverse maternal or perinatal outcome.
Viral infection may predispose to microbial pro-
ducts. Recent studies suggest that systemic viral
infections may predispose pregnant mice to the
Fig. 6 Forest plot of hazard ratios for spontaneous preterm delivery
(<37, <32 weeks) by PCR/ESI-MS and amniotic fluid culture results
compared with patients with negative tests. The risks of spontaneous
preterm delivery (sPTD) <37 and, separately, <32 weeks were
significantly greater among patients with positive PCR/ESI-MS (GE/well
≥17), both with and without positive AF cultures, when compared to
women with negative tests.
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effect of microbial products such as endotoxin.242
Specifically, pregnant mice infected with a herpesvirus
were more likely to have spontaneous preterm labor
and deliver following endotoxin administration than
those not exposed to the virus.242,243 Further work
is required to determine whether this is a mechanism
of disease operative in humans. It is well known
that viral infections of the respiratory tract predispose
to bacterial infections and pneumonia.244–247 The
same may be the case in the lower genital tract.248
However, if the viral infections are not systemic
(and associated with a symptomatic state), but are
localized to the uterine cervix or other parts of the
genital tract the identification of subclinical infection
would pose an important challenge. Yet, given the
high prevalence and diversity of viruses, as well as
the severity of the consequences of viral predisposi-
tion to bacterial infections, this possibility deserves
further study.
True-Positive, False-Negative, and False-Positive
PCR/ESI-MS Results
A challenge when interpreting the results of molecu-
lar microbiologic techniques is differentiating true-
from false-positive results. PCR methods can amplify
extremely small quantities of microbial DNA such
that contamination of a specimen may appear as a
positive result.
In this study, we used the host response to
microbial invasion (e.g., intra-amniotic inflamma-
tion, acute histologic chorioamnionitis, and the
onset of spontaneous preterm delivery) to assess
the clinical significance of microbial detection by
PCR/ESI-MS. We found that the microbial burden
(expressed as gene copies/well) was significantly
correlated with each marker of intra-amniotic
inflammation, even when excluding patients with
positive AF cultures. The prevalence of intra-amni-
otic inflammation and acute histologic chorioam-
nionitis in patients with negative cultures and
positive PCR/ESI-MS was 90% and 70%, respec-
tively. Patients with positive PCR/ESI-MS results
and negative AF cultures also had a significantly
shorter interval to spontaneous preterm delivery
than women with negative tests. Moreover, neo-
nates born to mothers with positive PCR/ESI-MS
and negative AF cultures were at five-fold greater
risk of perinatal mortality than those born to
mothers with negative tests. Together, these find-
ings strongly support the conclusion that a positive
PCR/ESI-MS (≥17 GE/well) result represents a
true-positive finding, even when AF cultures are
negative.
Bacterial cultures are considered a sensitive test
for the identification of microorganisms when the
conditions for supporting growth of that particular
microorganism are optimal. Even one organism can
form a colony in culture under ideal circumstances;
yet, one organism may be insufficient for detection
using PCR methods.249 In previous studies, we iden-
tified patients with positive AF cultures who had
negative PCR using broad primers and specific
assays.94,99,101,193 These results were attributed to
possible DNA degradation,250 low inoculum size,251
etc. The observations made in the current study sug-
gest that false-negative PCR/ESI-MS results are an
extremely rare phenomenon. None of the three
Fig. 7 Prevalence of perinatal death (fetal
and neonatal deaths) by the combined
results of amniotic fluid culture and PCR/ESI-
MS. Patients with positive PCR/ESI-MS (≥17
GE/well) and negative AF cultures had
significantly higher rates of perinatal mortality
than women with both tests negative [40%
(4/10) versus 11% (13/122); (P = 0.03)]. There
was no difference in the rate of perinatal
death for offspring of women with positive
PCR/ESI-MS according to the results of AF
culture [positive culture 29% (2/7) versus
negative culture 40% (4/10); P = 1.0].
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Table V Microbial Invasion of the Amniotic Cavity (MIAC) in Obstetric Disorders as Determined by Amniotic Fluid Studies Obtained by
Transabdominal Amniocentesis Using Cultivation Techniques
Obstetric disorders Authors
Prevalence of MIAC
% (n/N)
Spontaneous labor at term with intact membranes Romero et al.62 18.8 (17/90)
Gomez et al.63 15.6 (14/90)
Yoon et al.149 6.3 (12/190)
Preterm labor with intact membranes Miller et al.9 20 (15)
Bobbit et al.11 25 (8/31)
Wallace and Herrick10 12 (3/25)
Wahbeh et al.12 21.2 (7/33)
Hameed et al.13 10.8 (4/37)
Weible and Randall352 3 (1/35)
Leigh et al.15 12 (7/59)
Gravett et al.14 24 (13/54)
Duff and Kopelman353 4 (1/24)
Romero et al.16 9.8 (4/41)
Romero et al.20 9.1 (24/264)
Skoll et al.21 5.5 (7/127)
Romero et al.20 9.1 (24/64)
Romero et al.23 13.8 (15/109)
Romero et al.22 13.7 (23/168)
Romero et al.24 12.8 (25/195)
Harger et al.354 0 (0/38)
Gauthier et al.25 15.9 (18/113)
Coultrip et al.27 11.2 (12/107)
Watts et al.26 19 (20/105)
Romero et al.61 9.2 (11/120)
Coultrip et al.355 13 (12/89)
Yoon et al.356 10.8 (11/102)
Markenson et al.196 9.3 (5/54)
Gomez et al.32 10.7 (11/103)
Hussey et al.31 12.6 (16/127)
Kara et al.357 33.8 (25/74)
Oyarzun et al.358 12 (6/50)
Rizzo et al.33 12.5 (18/144)
Greci et al.359 8.7 (9/103)
Yoon et al.30 11.6 (21/181)
Elimian et al.35 11.5 (12/104)
Gonzalez/Bosquet et al.36 11.5 (13/113)
Locksmith et al.37 13.6 (6/44)
Ovalle et al.38 23.8 (15/63)
Yoon et al.41 10 (21/209)
Pre-labor premature rupture of membranes without labor Garite et al.50 30 (9/30)
Garite and Freeman360 23.3 (20/86)
Cotton et al.52 17 (7/41)
Zlatnik et al.361 31 (9/29)
Broekhuizen et al.66 28.3 (15/53)
Vintzileos et al.362 22.2 (12/54)
Felnstein et al.363 20 (12/50)
Romero et al.53 25.6 (41/160)
Gauthier et al.25 53.8 (49/91)
Coultrip et al.27 41.4 (12/29)
Gauthier and Meyer364 47.9 (56/117)
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patients with positive AF cultures and negative PCR/
ESI-MS results in this study had intra-amniotic
inflammation, only one had mild acute histologic
chorionitis/subchorionitis, and all three delivered
after 35 weeks of gestation without major complica-
tions. It is doubtful that positive AF culture with
negative PCR/ESI-MS results constitutes a true-posi-
tive culture.
Acidovorax sp. was identified by PCR/ESI-MS in
one patient who had a negative AF culture. The
microbial burden in this case was low (11 GE/well),
the AF Gram stain was negative, and there was no
evidence of intra-amniotic inflammation (by AF IL-
6, glucose, WBC count, or acute histologic chorio-
amnionitis); yet, the patient delivered before the
28th week of gestation. Acidovorax sp. has been iden-
tified as a contaminant in other studies,252–254 and
thus, it is unlikely that PCR/ESI-MS identified a true
infection, responsible for the process that led to pre-
term delivery. Preterm labor, in this case, is most
likely attributable to a mechanism other than intra-
amniotic infection. Further studies are necessary to
investigate the frequency of false-positive and false-
negative PCR/ESI-MS results using fresh samples
collected in a clinical setting.
Potential Clinical Value of the Rapid Detection of
MIAC in Preterm Labor
Therapy to reduce the rate of preterm birth in
patients with symptoms of preterm labor has focused
almost exclusively on tocolytic agents.255–265 How-
ever, these efforts have had limited suc-
cess.262,264,266–268 This is partly attributable to the
syndromic nature of preterm labor,164,165,218,269–271
which may require an etiology-based approach to
diagnosis, treatment, and prevention.
MIAC and subclinical intra-amniotic inflammation
are implicated in at least one-third of the cases of
spontaneous preterm labor and delivery.7–43,155,156
Furthermore, intra-amniotic infection has been rec-
ognized as predisposing to cerebral palsy272–284 and
chronic lung disease.41,285–300 However, with the
exception of asymptomatic bacteriuria,301–305 pro-
phylactic antibiotic treatment has not been success-
ful in the prevention of preterm birth,306–330 and
Table V (Continued)
Obstetric disorders Authors
Prevalence of MIAC
% (n/N)
Romero et al.60 38.2 (42/110)
Font et al.365 56.8 (21/37)
Averbuch et al.366 35.6 (32/90)
Carroll et al.367 30.9 (30/97)
Gomez et al.32 57.7 (30/52)
Hussey et al.31 15.4 (4/26)
Pre-labor premature rupture of membranes in labor Romero et al.53 75 (36/48)
Spontaneous rupture of membranes at term Romero et al.59 34.3 (11/32)
Sonographic short cervix Gomez et al.368 7 (28/401)
Hassan et al.349 9 (5/57)
Vaisbuch et al.369 4.3 (2/47)
Cervical insufficiency Romero et al.160 51.5 (17/33)
Mays et al.161 39 (7/18)
Lee et al.162 8 (4/52)
Bujold et al.163 47 (7/15)
Twin gestations with preterm labor and intact membranes Romero et al.370 11.9 (5/42)
Mazor et al.371 12 (9/74)
Yoon et al.372 35 (7/20)
Meconium stained amniotic fluid in preterm gestations Romero et al.215 33 (10/30)
Meconium stained amniotic fluid in term gestations Romero et al.373 19.6 (16/66)
Placenta previa Madan et al.374 5.7 (2/35)
Idiopathic vaginal bleeding Gomez et al.375 14 (16/114)
Pregnancy with intra-uterine device Kim et al.376 45.9 (45/98)
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some have claimed that it may increase the rate of
preterm delivery.331
The lack of efficacy of antibiotics has been attrib-
uted to the inclusion in randomized clinical trials of
patients who do not have evidence of infection and
therefore cannot benefit from antimicrobial ther-
apy,308,313–319,321–323,325–330,332 the choice and timing
of antimicrobial agents,333 the presence of
biofilms334–339 in which bacteria are refractory to
antimicrobial treatment, etc. Benefits of antimicro-
bial treatment could include eradication of intra-
amniotic infection in early phases, down-regulation
of the inflammatory cascade that leads to preterm
labor and delivery, prevention of an exaggerated
inflammatory response syndrome that may cause
fetal injury, and even congenital neonatal sepsis.
Animal models of intra-amniotic infection have
shown that early administration of antibiotics at or
within 12 hours after inoculation of bacteria in AF
reduces the bacterial burden in blood, the perito-
neum, the uterus, and AF.333,340–342 Moreover, Gri-
gsby et al. have shown in a primate model of intra-
amniotic infection generated by the inoculation of
Ureaplasma parvum, that the administration of
azithromycin can eradicate Ureaplasma parvum from
the AF and fetal lungs, prolonging pregnancy.343
Eradication of MIAC with parenteral antibiotics has
also been documented in patients with a short cer-
vix as well as in patients with preterm labor.344–348
For example, Hassan et al. reported that in patients
with short cervix and positive AF culture for Ureapl-
asma urealyticum, AF cultures were sterile following
7 days of intravenous azithromycin, and three of
the four cases delivered at term.349
The rapid, high-throughput technique used in this
study is a promising option that facilitates broader
and faster identification of MIAC in patients with
preterm labor and intact membranes and is applica-
ble to other complications of pregnancy. Accord-
ingly, this technique may render standard
cultivation methods of limited value, as it would
allow targeting of specific interventions for at-risk
patients, including hospitalization, delivery, or trans-
fer to high-level facilities with specialized neonatal
care. Future studies are required to clarify whether
timely administration of specific antibiotic therapy
for intra-amniotic infection could improve perinatal
outcomes. Yet, as noted previously by our
group,308,344,345,350,351 such studies may be difficult
to conduct under the current framework of regula-
tions protecting human subjects from research risks,
because withholding antimicrobial therapy from
immune-compromised patients (the human fetus)
would most likely be ethically unacceptable.
Strengths and Limitations
This is the first report of the use of PCR/ESI-MS in
AF, as well as the first direct comparison of this
technology with standard cultivation techniques.
The results provide evidence that microbial burden
has clinical implications. Future work is are required
to assess the performance of PCR/ESI-MS in freshly
collected samples.
Conclusion
(i) Rapid diagnosis of MIAC is possible using PCR/
ESI-MS, which can provide results within 8 hours;
(ii) the combined use of biomarkers of inflammation
and PCR/ESI-MS allows for the diagnosis of intra-
amniotic inflammation and infection; and (iii) this
approach may result in the implementation of timely
and specific interventions to reduce morbidity attrib-
uted to infection-induced preterm birth.
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